Revision of the Hip Joint - Prospective Study
Study Overview
Status
Status
Conditions
Conditions
Study Type
Study Type
Contacts and Locations
Study Contact
Study Contact
- Name: Gurion Rivkin
- Phone Number: 972-2-6776342
- Email: Gurion@hadassah.org.il
Study Locations
-
-
-
Jerusalem, Israel
- Hadassah Medical Organization
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients that underwent a revision of the hip replacement without removing the acetabular implant
- Insert polyethylene with cement
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
|---|
|
Revison of the hip joint
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
|---|---|
|
Quality of life
|
Quality of life as measured by the SF12 questionnaire.
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
|---|---|
|
Function
|
Function as measured by the Haris Hip Score
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- rivk-001-HMO-CTIL
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.